Evidence map›Paper›PMID 33486890›Full record

ArticleBrain and behavior2021

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.

Francisco Carlos Pérez-Miralles, Daniel Prefasi, Antonio García-Merino, José Ramón Ara, Guillermo Izquierdo, Virginia Meca-Lallana, Francisco Gascón-Giménez, María Luisa Martínez-Ginés, Lluis Ramió-Torrentà, Lucienne Costa-Frossard and 5 more

Abstract read
In one paragraph

Article in Brain and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Francisco Carlos Pérez-MirallesNeuroimmunology Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.ORCID 0000-0003-3767-3738
Daniel PrefasiDepartment of Medical, Roche Farma S.A, Madrid, Spain.ORCID 0000-0001-7595-339X
Antonio García-MerinoDepartment of Neurology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
José Ramón AraDepartment of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.ORCID 0000-0002-9788-2083
Guillermo IzquierdoDepartment of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
Virginia Meca-LallanaDepartment of Neurology, Hospital Universitario La Princesa, Madrid, Spain.
Francisco Gascón-GiménezDepartment of Neurology, Hospital Clínico Universitario de Valencia, Valencia, Spain.
María Luisa Martínez-GinésDepartment of Neurology, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Lluis Ramió-TorrentàGirona Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Universitari Josep Trueta and Hospital Santa Caterina, IDIBGI, Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.ORCID 0000-0002-6999-1004
Lucienne Costa-FrossardDepartment of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Óscar FernándezDepartment of Neurology, Hospital Regional Universitario Carlos Haya, Málaga, Spain.
Sara Moreno-GarcíaDepartment of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Jorge MaurinoDepartment of Medical, Roche Farma S.A, Madrid, Spain.ORCID 0000-0001-9858-3555
Joan Carreres-PoloDepartment of Radiology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.ORCID 0000-0003-2667-2019
Bonaventura CasanovaNeuroimmunology Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeEvidence on regional changes resulting from neurodegenerative processes underlying primary progressive multiple sclerosis (PPMS) is still limited. We assessed brain region volumes and their relationship with disability progression and cognitive function in PPMS patients.

methodsThis was an MRI analysis of 43 patients from the prospective Understanding Primary Progressive Multiple Sclerosis (UPPMS) cohort study. MRI scans were performed within 3 months before enrollment and at month 12.

resultsGray matter volume of declive and white matter volumes adjacent to left straight gyrus, right calcarine sulcus, and right inferior occipital gyrus significantly decreased from baseline to month 12. Baseline white matter volumes adjacent to right amygdala and left cuneus significantly differed between patients with and without disability progression, as well as baseline gray matter volumes of left cuneus, right parahippocampal gyrus, right insula, left superior frontal gyrus, declive, right inferior temporal gyrus, right superior temporal gyrus (pole), and right calcarine sulcus. Baseline gray matter volumes of right cuneus and right superior temporal gyrus positively correlated with 12-month Selective Reminding Test and Word List Generation performance, respectively. Gray matter changes in right superior semilunar lobe and white matter adjacent to left declive and right cerebellar tonsil also positively correlated with Word List Generation scores, while white matter change in left inferior semilunar lobe positively correlated with Symbol Digit Modalities Test performance after 12 months.

conclusionsWhite and gray matter volumes of specific brain regions could predict disability progression and cognitive performance of PPMS patients after one year.

Indexed as

Multiple SclerosisMultiple Sclerosis, Chronic ProgressiveBrainCognitionCohort StudiesGray MatterHumansMagnetic Resonance ImagingProspective Studiesbrain volumecognitive functiondisability progressionmagnetic resonance imagingprimary progressive multiple sclerosis

Identifiers

PMID33486890
PMCPMC8035443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.